NDC 55154-5446

Ceftriaxone Sodium

Ceftriaxone Sodium

Ceftriaxone Sodium is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Ceftriaxone Sodium.

Product ID55154-5446_a76602b6-9420-452e-9bee-5b68c0ec275c
NDC55154-5446
Product TypeHuman Prescription Drug
Proprietary NameCeftriaxone Sodium
Generic NameCeftriaxone Sodium
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2005-05-09
Marketing CategoryANDA / ANDA
Application NumberANDA065169
Labeler NameCardinal Health
Substance NameCEFTRIAXONE SODIUM
Active Ingredient Strength1 g/1
Pharm ClassesCephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 55154-5446-5

5 VIAL, SINGLE-USE in 1 BAG (55154-5446-5) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE
Marketing Start Date2005-05-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55154-5446-5 [55154544605]

Ceftriaxone Sodium INJECTION, POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA065169
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-05-09
Marketing End Date2018-06-30

Drug Details

Active Ingredients

IngredientStrength
CEFTRIAXONE SODIUM1 g/1

OpenFDA Data

SPL SET ID:bd58b065-5926-4671-8328-7cdc662b6988
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1665021
  • UPC Code
  • 0055154544658
  • Pharmacological Class

    • Cephalosporin Antibacterial [EPC]
    • Cephalosporins [CS]

    NDC Crossover Matching brand name "Ceftriaxone Sodium" or generic name "Ceftriaxone Sodium"

    NDCBrand NameGeneric Name
    0409-7332Ceftriaxone SodiumCeftriaxone Sodium
    0409-7333Ceftriaxone SodiumCeftriaxone Sodium
    0409-7334Ceftriaxone SodiumCeftriaxone Sodium
    0409-7335Ceftriaxone SodiumCeftriaxone Sodium
    0409-7336Ceftriaxone SodiumCeftriaxone Sodium
    0409-7337Ceftriaxone SodiumCeftriaxone Sodium
    0409-7338Ceftriaxone SodiumCeftriaxone Sodium
    68071-1828Ceftriaxone SodiumCeftriaxone Sodium
    68071-1829Ceftriaxone SodiumCeftriaxone Sodium
    68071-4682Ceftriaxone SodiumCeftriaxone Sodium
    70518-0168Ceftriaxone SodiumCeftriaxone Sodium
    70518-0659Ceftriaxone SodiumCeftriaxone Sodium
    70518-1893Ceftriaxone SodiumCeftriaxone Sodium
    0781-3208Ceftriaxone SodiumCeftriaxone Sodium
    0781-3207Ceftriaxone SodiumCeftriaxone Sodium
    0781-3206Ceftriaxone SodiumCeftriaxone Sodium
    0781-3209Ceftriaxone SodiumCeftriaxone Sodium
    0781-3210Ceftriaxone SodiumCeftriaxone Sodium
    0781-9328Ceftriaxone SodiumCeftriaxone Sodium
    0781-9326Ceftriaxone SodiumCeftriaxone Sodium
    0781-9327Ceftriaxone SodiumCeftriaxone Sodium
    0781-9329Ceftriaxone SodiumCeftriaxone Sodium
    21695-202Ceftriaxone SodiumCeftriaxone Sodium
    21695-352Ceftriaxone SodiumCeftriaxone Sodium
    43858-632Ceftriaxone SodiumCeftriaxone Sodium
    43858-631Ceftriaxone SodiumCeftriaxone Sodium
    43858-634Ceftriaxone SodiumCeftriaxone Sodium
    43858-637Ceftriaxone SodiumCeftriaxone Sodium
    43858-633Ceftriaxone SodiumCeftriaxone Sodium
    43858-635Ceftriaxone SodiumCeftriaxone Sodium
    43858-636Ceftriaxone SodiumCeftriaxone Sodium
    50090-0944Ceftriaxone SodiumCeftriaxone Sodium
    50090-3810Ceftriaxone SodiumCeftriaxone Sodium
    50090-2444Ceftriaxone SodiumCeftriaxone Sodium
    50090-3838Ceftriaxone SodiumCeftriaxone Sodium
    50090-3447Ceftriaxone SodiumCeftriaxone Sodium
    55154-5446Ceftriaxone SodiumCeftriaxone Sodium
    60505-6149Ceftriaxone SodiumCeftriaxone Sodium
    60505-6150Ceftriaxone SodiumCeftriaxone Sodium
    60505-6151Ceftriaxone SodiumCeftriaxone Sodium
    60505-6148Ceftriaxone SodiumCeftriaxone Sodium
    60505-6152Ceftriaxone SodiumCeftriaxone Sodium
    67184-1005Ceftriaxone SodiumCeftriaxone Sodium
    0338-5002CeftriaxoneCeftriaxone Sodium
    0338-5003CeftriaxoneCeftriaxone Sodium

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.